Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 2,658
Avg Vol 12,124
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 87%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. AccuStem Sciences, Inc. was...

Industry: Biotechnology
Sector: Healthcare
Address:
5 Penn Plaza, 19th Floor #1954, New York, United States
Tradephoenix
Tradephoenix Jun. 16 at 2:46 PM
$ACUT more buying again https://accustem.com/accustem-sciences-inc-announces-chairman-purchase-of-shares-8/
0 · Reply
Clipper100
Clipper100 Jun. 15 at 9:18 AM
$ACUT I wonder where could end up 😀 !! Buy in 2026 at what €??
1 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 14 at 6:38 AM
$ACUT Full steam ahead, $2 next stop📈🚀
0 · Reply
Reporich1
Reporich1 Jun. 13 at 10:47 PM
$ACUT I can't even remember how I ended up with shares of this? A spinoff or something? Does anyone follow them enough to give a quick idea if its worth holding onto? Thanks
1 · Reply
dino068
dino068 Jun. 13 at 6:13 PM
$ACUT This can squeeze to $5 ! No float and longs are not selling!! The real investors know what’s coming !
0 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 13 at 5:09 PM
$TLSA $ACUT Tizzy and Accustem both looking super bullish today 🐂 📈🚀
0 · Reply
Tradephoenix
Tradephoenix Jun. 13 at 1:17 PM
$ACUT more buying https://x.com/accustem/status/1933483990423392430?s=46&t=HqWhscg92m9uV_YSVozALA
0 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 12 at 7:01 PM
@MakingDreamsReality $ACUT News about to drop?
1 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 12 at 6:59 PM
@OpenOutcrier $ACUT News about to drop?
0 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 12 at 6:25 PM
$ACUT Intriguing investment case here. Due to the nature of the demerger it’s impossible to decipher who owns stock and who has sold. An enormous eruption could genuinely be upon the horizon here🚀📈
0 · Reply
Latest News on ACUT
No data available.
Tradephoenix
Tradephoenix Jun. 16 at 2:46 PM
$ACUT more buying again https://accustem.com/accustem-sciences-inc-announces-chairman-purchase-of-shares-8/
0 · Reply
Clipper100
Clipper100 Jun. 15 at 9:18 AM
$ACUT I wonder where could end up 😀 !! Buy in 2026 at what €??
1 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 14 at 6:38 AM
$ACUT Full steam ahead, $2 next stop📈🚀
0 · Reply
Reporich1
Reporich1 Jun. 13 at 10:47 PM
$ACUT I can't even remember how I ended up with shares of this? A spinoff or something? Does anyone follow them enough to give a quick idea if its worth holding onto? Thanks
1 · Reply
dino068
dino068 Jun. 13 at 6:13 PM
$ACUT This can squeeze to $5 ! No float and longs are not selling!! The real investors know what’s coming !
0 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 13 at 5:09 PM
$TLSA $ACUT Tizzy and Accustem both looking super bullish today 🐂 📈🚀
0 · Reply
Tradephoenix
Tradephoenix Jun. 13 at 1:17 PM
$ACUT more buying https://x.com/accustem/status/1933483990423392430?s=46&t=HqWhscg92m9uV_YSVozALA
0 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 12 at 7:01 PM
@MakingDreamsReality $ACUT News about to drop?
1 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 12 at 6:59 PM
@OpenOutcrier $ACUT News about to drop?
0 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 12 at 6:25 PM
$ACUT Intriguing investment case here. Due to the nature of the demerger it’s impossible to decipher who owns stock and who has sold. An enormous eruption could genuinely be upon the horizon here🚀📈
0 · Reply
AOCashMoney
AOCashMoney Jun. 9 at 8:22 PM
$ACUT scam
3 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 8 at 8:43 AM
$ACUT The price movement has been more sensitive this week in an upward trajectory. Maybe the seller/s have paused selling or sold completely. 📈🚀
0 · Reply
Tradephoenix
Tradephoenix Jun. 3 at 6:06 PM
$ACUT https://pmc.ncbi.nlm.nih.gov/articles/PMC12125938/
0 · Reply
Bhanu82
Bhanu82 May. 31 at 8:13 PM
$ACUT https://www.england.nhs.uk/2025/05/nhs-first-in-world-to-roll-out-revolutionary-blood-test-for-cancer-patients/
1 · Reply
ROCKETMANZ
ROCKETMANZ Apr. 28 at 3:50 PM
$ACUT The lung cancer market is huge with massive growth expected. There’s a reason the main man, Executive Chairman Gabriele Cerrone keeps buying shares, he knows the SP is going to explode and will be ripe for acquisition by a big player 📈🚀
0 · Reply
ROCKETMANZ
ROCKETMANZ Apr. 28 at 3:44 PM
$ACUT I genuinely believe the company are very keen to commercialise in 2026 to capitalise before a better test becomes available in the future. It could be 5-10 years away and possibly linked to the advances in artificial intelligence but in the meantime there’s a fantastic window available to do very well indeed 📈🚀
0 · Reply
ROCKETMANZ
ROCKETMANZ Apr. 28 at 3:38 PM
$ACUT Feeling very excited for Accustem, here’s why: 📈🚀 The LDCT scan is the existing market leader for the lung cancer diagnostics market. In terms of accuracy, it has it’s deficiencies and there is a genuine gap in the market for a better test. The MSC test from Accustem is a blood test that works alongside the market leader to increase accuracy. Being a blood test, it will be relatively cost effective and an absolute no brainer for physicians and medical insurance providers, improving the chances for patients.
0 · Reply
ROCKETMANZ
ROCKETMANZ Apr. 28 at 3:15 PM
$ACUT https://accustem.com/accustem-sciences-inc-and-emeritusdx-announce-partnership-to-commercialize-msc-test-for-lung-cancer-screening/
0 · Reply
Tradephoenix
Tradephoenix Apr. 22 at 7:20 PM
$ACUT GC bought again https://x.com/accustem/status/1914273155771929017?s=46&t=HqWhscg92m9uV_YSVozALA
0 · Reply
Tradephoenix
Tradephoenix Apr. 17 at 2:48 PM
$ACUT commercialisation early 2026
0 · Reply
ROCKETMANZ
ROCKETMANZ Apr. 16 at 1:45 PM
$ACUT Another building block in place 📈🚀 https://accustem.com/accustem-sciences-inc-signs-agreement-to-access-blood-samples-from-lung-cancer-screening-trial-to-expedite-msc-commercialization-plan/
0 · Reply
ROCKETMANZ
ROCKETMANZ Apr. 10 at 11:20 AM
$ACUT $TLSA Similar to Trump telling people to buy yesterday, Cerrone is basically doing the same thing with his daily buying📈🚀
0 · Reply